Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity of type 2 innate lymphoid cells
Hergen Spits, Jenny Mjösberg
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 701-712
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

IL-4 and IL-13: Regulators and Effectors of Wound Repair
Judith E. Allen
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 229-254
Open Access | Times Cited: 73
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 48
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Zhenlong Li, Rui Ma, Hejun Tang, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 624-641.e23
Closed Access | Times Cited: 28
Sex differences orchestrated by androgens at single-cell resolution
Fei Li, Xudong Xing, Qiqi Jin, et al.
Nature (2024) Vol. 629, Iss. 8010, pp. 193-200
Closed Access | Times Cited: 26
The role of NLRP3 inflammasome in type 2 inflammation related diseases
Xu Shenming, Dan Wang, Lina Tan, et al.
Autoimmunity (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 23
The impact of type 2 immunity and allergic diseases in atherosclerosis
Nieves Fernández‐Gallego, Raquel Castillo‐González, Nerea Méndez‐Barbero, et al.
Allergy (2022) Vol. 77, Iss. 11, pp. 3249-3266
Open Access | Times Cited: 41
The ins and outs of innate and adaptive type 2 immunity
Ari B. Molofsky, Richard M. Locksley
Immunity (2023) Vol. 56, Iss. 4, pp. 704-722
Open Access | Times Cited: 35
Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions
Alex Watterson, Matthew A. Coelho
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice
William E. LeSuer, Melanie Kienzl, Sergei I. Ochkur, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 469-485.e10
Open Access | Times Cited: 22
Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivity
Benjamin P. Hurrell, Stephen Shen, X. Li, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 5
Open Access | Times Cited: 10
TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
Pauline Schmitt, Anais Dufros Duval, M. Camus, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 8
Diversity of group 1 innate lymphoid cells in human tissues
Natália Jaeger, Alina Ulezko Antonova, Daniel Kreisel, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1460-1473
Closed Access | Times Cited: 8
Reinventing type 2 immunity in cancer
Marek Wagner, Hiroyoshi Nishikawa, Shigeo Koyasu
Nature (2025) Vol. 637, Iss. 8045, pp. 296-303
Closed Access | Times Cited: 1
Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death
Fabiana Drommi, Alessia Calabrò, Gaetana Pezzino, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 263-263
Open Access | Times Cited: 1
Graphene oxide elicits microbiome-dependent type 2 immune responses via the aryl hydrocarbon receptor
Guotao Peng, Hanna Sinkko, Harri Alenius, et al.
Nature Nanotechnology (2022) Vol. 18, Iss. 1, pp. 42-48
Open Access | Times Cited: 31
Transcriptional control of ILC identity
Anna А. Korchagina, Sergey A. Shein, Ekaterina P. Koroleva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Metabolism in type 2 immune responses
Agnieszka M. Kabat, Erika L. Pearce, Edward J. Pearce
Immunity (2023) Vol. 56, Iss. 4, pp. 723-741
Open Access | Times Cited: 17
Blocking the HIF‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function
Xiaogang Zhang, Jingping Liu, Xinyao Li, et al.
Allergy (2024)
Open Access | Times Cited: 7
Tissue-specific features of innate lymphoid cells in antiviral defense
Sytse J. Piersma
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 9, pp. 1036-1050
Open Access | Times Cited: 6
Epithelial-neuronal-immune cell interactions: Implications for immunity, inflammation, and tissue homeostasis at mucosal sites
Elizabeth Emanuel, Mohammad Arifuzzaman, David Artis
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1169-1180
Closed Access | Times Cited: 5
IL-18 activates mucosal group 2 innate lymphoid cells following enteric bacterial infection
Rita Berkachy, Vishwas Mishra, Priyanka Biswas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell
Simone E. M. Olsthoorn, Anneloes van Krimpen, Rudi W. Hendriks, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access
An intraepithelial ILC1-like natural killer cell subset produces IL-13
Sainiteesh Maddineni, Krishna Sharma, Imran Mohammad, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ruminant Innate lymphoid cells
Ian R. Tizard
Elsevier eBooks (2025), pp. 175-192
Closed Access
Interleukin-33: A new frontier in cancer immunotherapy
Amrita Kaur, Kevin J. Bittorf, Ayan Chanda, et al.
International review of cell and molecular biology (2025)
Closed Access
Page 1 - Next Page

Scroll to top